Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5326
ACV Auctions
ACVA
$1.36B
| $2.27M | ﹤0.01% |
105,276
+31,501
| +43% | +$637K |
|
5327
CALL
PVH
PVH
$3.71B
| $2.27M | ﹤0.01% |
21,500
-127,200
| -86% | -$13M |
|
5328
CALL
LendingTree
TREE
$450M
| $2.27M | ﹤0.01% |
58,600
+12,000
| +26% | +$575K |
|
5329
FormFactor
FORM
$10.7B
| $2.27M | ﹤0.01% |
51,511
+31,166
| +153% | +$1.34M |
|
5330
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$507M
| $2.27M | ﹤0.01% |
62,978
+44,041
| +233% | +$1.66M |
|
5331
Colliers International
CIGI
$5.25B
| $2.27M | ﹤0.01% |
16,665
+1,248
| +8% | +$184K |
|
5332
3D Systems Corp
DDD
$623M
| $2.27M | ﹤0.01% |
690,571
+531,669
| +335% | +$1.7M |
|
5333
CALL
AudioEye
AEYE
$99.3M
| $2.26M | ﹤0.01% |
148,800
+51,500
| +53% | +$1.18M |
|
5334
PUT
Travere Therapeutics
TVTX
$5.87B
| $2.26M | ﹤0.01% |
129,900
-26,600
| -17% | -$470K |
|
5335
Rhythm Pharmaceuticals
RYTM
$7.97B
| $2.26M | ﹤0.01% |
40,419
-62,359
| -61% | -$3.44M |
|
5336
Smith & Nephew
SNN
$12.4B
| $2.26M | ﹤0.01% |
92,029
+19,818
| +27% | +$525K |
|
5337
CALL
ZTO Express
ZTO
$17.4B
| $2.26M | ﹤0.01% |
115,700
+40,100
| +53% | +$880K |
|
5338
CALL
La-Z-Boy
LZB
$1.65B
| $2.26M | ﹤0.01% |
51,900
-23,500
| -31% | -$993K |
|
5339
CALL
Cellebrite
CLBT
$2.77B
| $2.26M | ﹤0.01% |
102,600
+12,600
| +14% | +$243K |
|
5340
PUT
BellRing Brands
BRBR
$1.21B
| $2.26M | ﹤0.01% |
30,000
-600
| -2% | -$42.6K |
|
5341
Hancock Whitney
HWC
$6.41B
| $2.26M | ﹤0.01% |
+41,301
| New | +$2.29M |
|
5342
CALL
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $2.26M | ﹤0.01% |
45,400
-2,000
| -4% | -$105K |
|
|
OBDE
5343
DELISTED
Blue Owl Capital Corporation III
OBDE
| $2.26M | ﹤0.01% |
156,696
+28,802
| +23% | +$424K |
|
5344
CALL
Wyndham Hotels & Resorts
WH
$5.41B
| $2.26M | ﹤0.01% |
22,400
-4,100
| -15% | -$381K |
|
5345
TriCo Bancshares
TCBK
$1.84B
| $2.26M | ﹤0.01% |
51,660
+38,464
| +291% | +$1.75M |
|
5346
Bank of Marin Bancorp
BMRC
$460M
| $2.26M | ﹤0.01% |
94,917
-10,543
| -10% | -$249K |
|
5347
ProShares Ultra Gold
UGL
$806M
| $2.25M | ﹤0.01% |
96,476
+14,848
| +18% | +$360K |
|
5348
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$253M
| $2.25M | ﹤0.01% |
117,295
+91,619
| +357% | +$1.84M |
|
5349
G-III Apparel Group
GIII
$1.41B
| $2.25M | ﹤0.01% |
69,079
-14,599
| -17% | -$459K |
|
5350
PUT
Manulife Financial
MFC
$73.9B
| $2.25M | ﹤0.01% |
73,300
+22,000
| +43% | +$682K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.